Neuroimaging and the neurobiology of obsessive-compulsive disorder;Neurobiologische korrelate der zwangsstörungen-aktuelle befunde zur funktionellen bildgebung

PPmP Psychotherapie Psychosomatik Medizinische Psychologie

Volumn 57, Issue 9-10, 2007, Pages 379-394

  Schiepek, Günter ^a,d   Tominschek, Igor ^b   Karch, Susanne ^c   Mulert, Christoph ^c   Pogarell, Oliver ^c  

^a UNIVERSITY OF KLAGENFURT   (Austria)

^b Psychosomatische Klinik Windach   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d Center for Complex Systems   (Germany)

Author keywords

fMRI; Functional neuroimaging; Obsessive compulsive disorder; Psychotherapy

Indexed keywords

AMYGDALOID NUCLEUS; BRAIN REGION; CEREBELLUM; CINGULATE GYRUS; ELECTROENCEPHALOGRAM; FACTORIAL ANALYSIS; FEAR; HUMAN; INSULA; NEUROBIOLOGY; NEUROIMAGING; OBSESSION; OBSESSIVE COMPULSIVE DISORDER; PARIETAL LOBE; PRIORITY JOURNAL; REVIEW;

BRAIN; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; OBSESSIVE-COMPULSIVE DISORDER;

EID: 35348932222     PISSN: 09372032     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-952021     Document Type: Review

References (158)

1. Zaudig M. Epidemiologie, Komorbidität und Verlauf der Zwangsstörung. In: Zaudig M, Hauke W, Hegerl U (Hrsg): Die Zwangsstörung. Diagnostik und Therapie. Stuttgart: Schattauer, 2002: 33-42
2. Karno M, Golding JN, Sorenson SB, Burmann MA. The epidemiology of obsessive-compulsive disorders in five US-Communities. Arch Gen Psychiatry 1988; 45: 1094-1099
3. Wittchen HU, Saß H, Zaudig M, Koehler K. Diagnostisches und Statistisches Manual psychischer Störungen (DSM-II-R). Deutsche Bearbeitung und Einführung. Weinheim: Beltz, 1989
4. Eaton WW, Kramer M, Anthony JC. The incidence of specific DIS/DSM-III mental disorders: Data from NIMH Epidemiologic Catchment Area Program. Acta Psychiatrica Scand 1989; 79: 163-187
5. Reinecker H, Zaudig M. Langzeiteffekte bei der Behandlung von Zwangsstörungen. Lengerich: Pabst, 1995
6. Weissman MM, Bland RC, Canino GJ et al. The cross national epidemiology of obsessive-compulsive disorder. J Clin Psychiatry 1994; 55 (Suppl): 5-10
7. Shafran R. Obsessive-compulsive disorder in children and adolescents. Child Psychol Psychiatry Rev 2001; 6: 50-58
8. Snider LA, Swedo SE. Pediatric obsessive-compulsive disorder. J Am Med Ass 2000; 284: 3104-3106
9. Stengler-Wenzke K, Beck M, Holzinger A, Angermeyer MC. Stigmatisierungserfahrungen von Patienten mit Zwangserkrankungen. Fortschr Neurologie Psychiatrie 2004; 72: 7-13
10. Eisen J, Rasmussen S. Clinical features of obsessive-compulsive disorder. Psych Clin North Am 2000; 23: 469-491
11. Sobin C, Blundell ML, Karayiorgou M. Phenotypic differences in early-and late-onset obsessive-compulsive disorder. Comp Psychiatry 2000; 41: 373-379
12. Rosario-Campos M, Leckmann J. Adults with early-onset obsessive-compulsive disorder. Am J Psychotherapy 2001; 158: 1899-1903
13. Millet B, Kochmann F, Gallarda T et al. Phenomenological and comorbid features associated in obsessive-compulsive disorder: Influence of age of onset. J Affective Dis 2004; 83: 283-284
14. Fontanelle LF, Mendlowicz M, Marques C, Versiani M. Early- and late-onset obsessive-compulsive disorder in adult patients: An exploratory clinical and therapeutic study. J Psychiatric Res 2003; 37: 127-133
15. Jänsch P. Der frühe Beginn der Zwangsstörung: Einfluss auf Symptomatik, Schweregrad und Komorbidität. Diplomarbeit an der Ludwig-Maximilian-Universität München, 2004
16. Piacentini J, Bergman L. Obsessive-compulsive disorder in children. Psych Clin North Am 2000; 23: 519-533
17. Pauls DL, Alsobrook JP. The inheritance of obsessive-compulsive disorder. Child Adol Psych Clin North Am 1999; 8: 481-496
18. Nestadt G, Lan T, Samuels J et al. Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogenetics by sex. Am J Human Gen 2000; 67: 1611-1616
19. Hegerl U, Henkel V, Pogarell O. Neurobiologische Erklärungsansätze bei Zwangsstörungen. Psychotherapie 2002; 7: 228-233
20. Nestadt G, Samuels J, Riddle M et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000; 57: 358-363
21. Hauke W. Die Effektivität von multimodaler Verhaltenstherapie bei Zwangsstörungen. Prax Klin Verhaltensmed Rehabilitation 1994; 26: 82-88
22. Reinecker H. Zwänge. Diagnose, Theorien und Behandlung. Bern: Huber, 1994
23. Zaudig M, Hauke W, Hegerl U. Die Zwangsstörung. Diagnostik und Therapie. Stuttgart: Schattauer, 2002
24. Lakatos A. Kognitiv-behaviorale Therapie für Zwangsstörungen. Regensburg: Roderer, 1997
25. Ambühl H, Meier B. Zwang verstehen und behandeln. Stuttgart: Pfeiffer bei Klett-Cotta, 2003
26. Tominschek I, Schiepek G. Zwangsstörungen. Ein systemisch-integratives Behandlungskonzept. Göttingen: Hogrefe, 2007 (im Druck)
27. Kordon A, Leplow B, Hohagen F. Zwangsstörungen. In: Förstl H, Hautzinger M, Roth G (Hrsg): Neurobiologie psychischer Störungen. Heidelberg: Springer Medizin Verlag, 2006: 545-576
28. Mavrogiorgou P, Hegerl U. Psychopharmakotherapie der Zwangsstörungen. In: Zaudig M, Hauke W, Hegerl U (Hrsg): Die Zwangsstörung. Diagnostik und Therapie. Stuttgart: Schattauer, 2002: 91-106
29. Kobak KA, Greist JH, Jefferson JW et al. Behavioral versus pharmacological treatments of obsessive-compulsive disorder: A meta-analysis. Psychopharmacology 1998; 136: 205-216
30. Hohagen F, Winkelmann G, Rasche-Ruchle H et al. Combination of behavioural therapy with fluvoxamine in comparison with behaviour therapy and placebo. Results of a multicentre study. Br J Psychiatry 1998; 35 (Suppl): 71-88
31. Rauch SL, Dougherty DD, Cosgrove GR et al. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry 2001; 50: 659-667
32. Mallet L, Mesnage V, Houeto JL et al. Compulsions, Parkinson's disease and stimulation. Lancet 2002; 360: 1302-1304
33. Tass PA. A model of desynchronization deep brain stimulation with a demand-controlled coordinated reset of neural subpopulation. Biol Cybernetics 2003; DOI: 1007/422-425
34. Arolt V, Rothermundt M. Psychische Erkrankungen und Immunsystem. Psychother Psychosom med Psychol 2005; 55: 36-48
35. Swedo SE, Leonard HL, Garvey M et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: Clinical description of the first 50 cases. Am J Psychiatry 1998; 155: 264-271
36. Kuelz AK, Hohagen F, Voderholzer U. Neuropsychological performance in obsessive-compulsive disorder: A critical review. Biol Psychology 2004; 65: 185-236
37. Aigner M, Zitterl W, Prayer D et al. Magnetic resonance imaging in patients with obsessive-compulsive disorder with good versus poor insight. Psychiatry Res - Neuroimaging 2005; 140: 173-179
38. Schiepek G (Hrsg). Neurobiologie der Psychotherapie. Stuttgart: Schattauer, 2004
39. Walter H (Hrsg). Funktionelle Bildgebung in Psychiatrie und Psychotherapie. Stuttgart: Schattauer, 2005
40. Schneider F, Fink GR (Hrsg). Funktionelle Magnetresonanztomographie in Psychiatrie und Neurologie. Heidelberg: Springer, 2007
41. Friedlander L, Desrocher M. Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin Psychol Rev 2006; 26: 32-49
42. Graybiel AM, Rauch SL. Toward a neurobiology of obsessive-compulsive disorder. Neuron 2000; 28: 343-347
43. Whiteside SP, Port JD, Abramowitz JS. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Res - Neuroimaging 2004; 132: 69-79
44. Zurowski B, Kordon A, Hohagen F. Zwangsstörungen. In: Walter H (Hrsg): Funktionelle Bildgebung in Psychiatrie und Psychotherapie. Stuttgart: Schattauer, 2005: 303-319
45. Stein DJ, Goodman WK, Rauch SL. The cognitive-affective neuroscience of obsessive-compulsive disorder. Curr Psychiatry Rep 2000; 2: 341-346
46. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging und frontal-subcortical circuitry in obsessive-compulsive disorder. Brit J Psychiatry 1998; 173 (Suppl): 26-37
47. Saxena S, Bota RG, Brody AL. Brain-behaviour relationships in obsessive-compulsive disorder. Sem Clin Neuropsychiatry 2001; 6: 82-101
48. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Am 2000; 23: 563-586
49. Rohen JW. Funktionelle Neuroanatomie. Stuttgart: Schattauer, 2001
50. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: Neural substrates of parallel processing. Trends Neurosci 1990; 13: 266-271
51. Wewetzer C, Jans T, Beck N et al. Interaktion, Familienklima, Erziehungsstile und Erziehungspraktiken in Familien mit einem zwangskranken Kind. Verhaltenstherapie 2003; 13: 10-18
52. Insel TR. Toward a neuroanatomy of obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 739-744
53. 123I]β-CIT SPECT. Am J Psychiatry 2004; 161: 2201-2206
54. Pogarell O, Hamann C, Pöpperl G et al. Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry 2003; 54: 1406-1413
55. Adams KH, Hansen ES, Pinborg LH et al. Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei. Int J Neuropsychopharm 2005; 8: 391-401
56. 11C]McN5652. Biol Psychiatry 2003; 54: 1414-1421
57. Stengler-Wenzke K, Muller U, Angermeyer MC et al. Reduced serotonin transporter availability in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci 2004; 254: 252-255
58. Hesse S, Muller U, Lincke T et al. Serotonin and dopamine transporter imaging in patients with obsessive-compulsive disorder. Psychiatry Res 2005; 140: 63-72
59. Denys D, Wee N van der, Janssen J et al. Low level of dopaminergic D2 receptor binding in obsessive-compulsive disorder. Biol Psychiatry 2004; 55: 1041-1045
60. Denys D, Zohar J, Westenberg HG. The role of dopamine in obsessive-compulsive disorder: Preclinical and clinical evidence. J Clin Psychiatry 2004; 65 (Suppl): 11-17
61. Kugaya A, Seneca NM, Snyder PJ et al. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration. Neuropsychopharmacology 2003; 28: 413-420
62. Pogarell O, Pöpperl G, Mulert C et al. SERT and DAT availabilities under citalopram treatment in obsessive-compulsive disorder. Europ J Neuropsychopharmacology 2005; 15: 521-524
63. Rolls ET. The functions of the orbitofrontal cortex. Brain Cog 2004; 55: 11-29
64. Davidson RJ, Jackson DC, Kalin N. Emotion, plasticity, context, and regulation: Perspectives from affective neuroscience. Psychol Bull 2000; 126: 890-909
65. Damasio AR. The somatic marker hypothesis and the possible functions of the prefrontal cortex. Phil Trans Roy Soc London - Series B. Biol Sci 1996; 351: 1413-1420
66. Damasio AR. Ich fühle, also bin ich. Die Entschlüsselung des Bewusstseins. München: List, 2001
67. Bechara A. Neurobiology of decision making: Risk and reward. Sem Clin Neuropsychiatry 2001; 6: 205-216
68. Bechara A, Damasio H, Tranel D, Damasio AR. Deciding advantageously before knowing the advantageous strategy. Science 1997; 275: 1293-1295
69. Maia TV, McClelland JL. A reexamination of the evidence for the somatic marker hypothesis: What participants really know in the Iowa gambling task. Proc Nat Acad Sci USA 2004; 101: 16075-16080
70. Schienle A, Schäfer A, Stark R et al. Neural responses of OCD patients towards disorder relevant, generally disgust-inducing and fear-inducing pictures. Int J Psychophysiology 2005; 57: 69-77
71. Iacoboni M, Zaidel E. Interhemispheric visuo-motor integration in humans: The role of the superior parietal cortex. Neuropsychologia 2004; 42: 419-425
72. Sirigu A, Duhamel JR, Cohen L et al. The mental representation of hand movements after parietal cortex damage. Science 1996; 273: 1564-1568
73. Bauer J. Warum ich fühle, was du fühlst. Hamburg: Hoffmann & Campe, 2005
74. Gallese V, Goldman A. Mirror neurons and the simulation theory of mind-reading. Trends Cog Sci 1999; 2: 493-500
75. Tallis F. The neuropsychology of obsessive-compulsive disorder: A review and consideration of clinical implications. Brit J Clin Psychol 1997; 36: 3-20
76. Ketter TA, Wang PW, Lembke A, Sachs N. Physiological and pharmacological induction of affect. In: Davidson RJ, Scherer KR, Goldsmith HH (eds): Handbook of affective sciences. Oxford: Oxford University Press, 2003: 930-962
77. Davidson RJ, Pizzagalli D, Nitschke JB, Putnam KM. Depression: Perspectives from affective neuroscience. Ann Rev Psychol 2002; 53: 545-547
78. Davidson RJ, Pizzagalli D, Nitschke JB, Kalin NH. Parsing the subcomponents of emotion and disorders of emotion: Perspectives from affective neuroscience. In: Davidson RJ, Scherer KR, Goldsmith HH (eds): Handbook of affective sciences. Oxford: Oxford University Press, 2003: 8-24
79. Carter CS, Braver TS, Barch TM et al. Anterior cingulate cortex, error detection, and the online monitoring of performance. Science 1998; 280: 747-749
80. Devinsky O, Morrell MJ, Vogt BA. Contributions of anterior cingulate cortex to behaviour. Brain 1995; 118: 279-306
81. Sanfey AG, Rilling JK, Aronson JA et al. The neural basis of economic decision-making in the Ultimatum Game. Science 2003; 300: 1755-1758
82. Adler CM, McDonough-Ryan P, Sax KW et al. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive-compulsive disorder. J Psychiatry Res 2000; 34: 317-324
83. Breiter HC, Rauch SL, Kwong KK et al. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 595-606
84. Cottraux J, Gerard D, Cinotti L et al. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive patients with checking rituals. Psychiatry Res 1996; 60: 101-112
85. Rauch SL, Jenike MA, Alpert NM et al. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry 1994; 51: 62-70
86. Cavedini P, Riboldi G, D'Annucci A et al. Decision-making heterogenity in obsessive-compulsive disorder: Ventromedial prefrontal cortex function predicts different treatment outcomes. Neuropsychologia 2002; 40: 205-211
87. Mayberg HS, Brannan SK, Mahurin RK et al. Cingulate function in depression: A potential predictor of treatment response. Neuroreport 1997; 8: 1057-1061
88. Pizzagalli D, Pascual-Marqui RD, Nitschke JB et al. Anterior cingulate activity as a predictor of degree of treatment response in major depression: Evidence from brain electrical tomography analysis. Am J Psychiatry 2001; 158: 405-415
89. Etkin A, Pittenger C, Polan HJ, Kandel ER. Toward a neurobiology of psychotherapy: Basic science and clinical applications. J Neuropsychiatry Clin Neurosci 2005; 17: 145-158
90. LeDoux JE. Emotion circuits in the brain. Ann Rev Neurosci 2000; 23: 155-184
91. LeDoux JE. Das Netz der Gefühle. Wie Emotionen entstehen. München: dtv, 2001
92. LaBar KS, LeDoux JE. Emotional learning circuits in animals and humans. In: Davidson RJ, Scherer KR, Goldsmith HH (eds): Handbook of affective sciences. Oxford: Oxford University Press, 2003: 52-65
93. Morris JS, Öhman A, Dolan RJ. A subcortical pathway to the right amygdala mediating "unseen" fear. PNAS USA 1999; 96: 1680-1685
94. Phillips ML, Mataix-Cols D. Patterns of neural response to emotive stimuli distinguish the different symptom dimensions of obsessive-compulsive disorder. CNS Spectrum 2004; 9: 275-283
95. Heuvel OA van den, Veltman DJ, Groenewegen HJ et al. Amygdala activity in obsessive-compulsive disorder with contamination fear: A study with oxygen-15 water positron emission tomography. Psychiatry Res - Neuroimaging 2004; 132: 225-237
96. Cannistraro PA, Wright CI, Wedig MM et al. Amygdala responses to human faces in obsessive-compulsive disorder. Biol Psychiatry 2004; 56: 916-920
97. Breiter HC, Rauch SL. Functional MRI and the study of OCD: From symptom provocation to cognitive-behavioral probes of corticostriatal systems and the amygdala. Neuroimage 1996; 4: 127-138
98. Pujol J, Soriano-Mas C, Alonso P et al. Mapping structure brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 720-730
99. Wright P, He G, Shapira NA et al. Disgust and the insula: fMRI responses to pictures of mutilation and contamination. Neuroreport 2004; 15: 2347-2351
100. Shapira NA, Liu Y, He AG et al. Brain activation by disgust-inducing pictures in obsessive-compulsive disorder. Biol Psychiatry 2003; 54: 751-756
101. Kim JJ, Lee MC, Kim J et al. Grey matter abnormalities in obsessive-compulsive disorder: Statistical parametric mapping of segmented magnetic resonance images. Brit J Psychiatry 2001; 179: 330-334
102. Jenike MA, Breiter HC, Baer L et al. Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. Arch Gen Psychiatry 1996; 53: 625-632
103. Nakao T, Nakagawa A, Yoshiura T et al. Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: A functional magnetic resonance imaging study. Biol Psychiatry 2005; 57: 901-910
104. Roth G, Dicke U. Funktionelle Neuroanatomie des limbischen Systems. In: Förstl H, Hautzinger M, Roth G (Hrsg): Neurobiologie psychischer Störungen. Heidelberg: Springer Medizin Verlag, 2006: 1-74
105. Heimer L. A new anatomical framework for neuropsychiatric disorders and drug abuse. Am J Psychiatry 2003; 160: 1726-1739
106. Cummings JL, Mega MS. Neuropsychiatry and behavioural neuroscience. New York: Oxford University Press, 2003
107. 18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Brit J Psychiatry 1995; 166: 244-250
108. Greisberg S, McKay D. Neuropsychology of obsessive-compulsive disorder: A review and treatment implications. Clin Psychol Rev 2003; 23: 95-117
109. Kathmann N. Neuropsychologie der Zwangsstörung. Göttingen: Hogrefe, 2007
110. Cavallaro R, Cavedini P, Mistretta P et al. Basal-cortical circuits in schizophrenia and obsessive-compulsive disorder: A controlled, double dissociation study. Biol Psychiatry 2003; 54: 437-443
111. Nielen MMA, Veltman DJ, Jong R de et al. Decision making performance in obsessive-compulsive disorder. J Affective Dis 2002; 69: 257-260
112. Elliott R, Rees G, Dolan RJ. Ventromedial prefrontal cortex mediates guessing. Neuropsychologia 1999; 37: 403-411
113. Abbruzzese M, Ferri S, Scarone S. The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: A double dissoziation experimental finding. Neuropsychologia 1997; 35: 907-912
114. Fernandez A, Pino Alonso M, Mataix-Cols D et al. Neuroactivation of the Tower of Hanoi in patients with obsessive-compulsive disorder and healthy volunteers. Rev Esp Med Nucl 2003; 22: 376-385
115. Rauch SL, Savage CR, Alpert NM et al. Probing striatal function in obsessive-compulsive disorder: A PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci 1997; 9: 568-573
116. Deckersbach T, Savage CR, Curran T et al. A study of parallel implicit and explicit information processing in patients with obsessive-compulsive disorder. Am J Psychiatry 2002; 159: 1780-1782
117. Pogarell O, Hegerl U. Bildgebende Verfahren bei Zwangsstörungen. Psychotherapie 2002; 7: 204-208
118. Mataix-Cols D, Conceicao do Rosario-Campos M, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005; 162: 228-238
119. Rauch SL, Dougherty DD, Shin LM et al. Neural correlates of factor-analyzed OCD symptom dimensions: A PET study. CNS Spectrum 1998; 3: 37-43
120. Saxena S, Brody AL, Maidment KM et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004; 161: 1038-1048
121. Mataix-Cols D, Wooderson S, Lawrence N et al. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Arch Gen Psychiatry 2004; 61: 564-576
122. Phillips ML, Marks IM, Senior C et al. A differential neural response in obsessive-compulsive patients with washing compared with checking symptoms to disgust. Psychol Med 2000; 30: 1037-1050
123. Lang PJ, Bradley MM, Cuthbert BN. International Affective Picture System (IAPS): Instruction manual and affective ratings. Gainesville, FL: Center for Research in Psychophysiology, University of Florida, 1997/2001
124. Kozak MJ, Foa EB. Obsessions, overvalued ideas, and delusions in obsessive-compulsive disorder. Behav Res Ther 1994; 32: 343-353
125. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th revised edition. Washington, DC: APA, 1994
126. McGuire PK, Bench CJ, Frith SD et al. Functional anatomy of obsessive-compulsive phenomena. Brit J Psychiatry 1994; 164: 459-468
127. Overbeck G, Michal M, Russ MO et al. Konvergenzen psychotherapeutischer und neurobiologischer Ergebniskontrolle bei einer schweren Zwangsstörung. Psychother Psychosom med Psychol 2004; 54: 73-81
128. Tolin DF, Abramowitz JS, Brigidi BD et al. Memory and memory confidence in obsessive-compulsive disorder. Behav Res Ther 2001; 39: 913-927
129. Pitman RK. A cybernetic model of obsessive-compulsive pathology. Compr Psychiatry 1987; 28: 334-343
130. Veen V van, Carter CC. The anterior cingulate as a conflict monitor: fMRI and ERP studies. Physiol Behav 2002; 77: 477-482
131. Veen V van, Carter CC. The timing of action-monitoring processes in the anterior cingulate cortex. J Cog Neurosci 2002; 14: 593-602
132. Gehring WJ, Himle JA, Nisenson LG. Action-monitoring dysfunction in obsessive-compulsive disorder. Psychol Sci 2000; 11: 1-6
133. Kiehl KA, Liddle PF, Hopfinger JB. Error processing and the rostral anterior cingulate: An event-related fMRI study. Psychophysiology 2000; 37: 216-223
134. Scheffers MK, Coles MGH, Bernstein P et al. Event-related brain potentials and error-related processing: An analysis of incorrect responses of go and no-go stimuli. Psychophysiology 1996; 33: 42-53
135. Veen V van, Holroyd CB, Cohen JD et al. Errors without conflict: Implications for performance monitoring theories of anterior cingulate cortex. Brain Cog 2004; 56: 267-276
136. Ursu S, Stenger VA, Shear MK et al. Overactive action monitoring in obsessive-compulsive disorder: Evidence from functional magnetic resonance imaging. Psychol Sci 2003; 14: 347-353
137. Maltby N, Tolin DF, Worhunsky P et al. Dysfunctional action monitoring hyperactivates frontal-striatal circuits in obsessive-compulsive disorder: An event-related fMRI study. Neuroimage 2005; 24: 495-503
138. Bush G, Whalen PJ, Rosen BR et al. The counting Stroop: An interference task specialized for functional neuroimaging-validation study with functional MRI. Hum Brain Mapping 1998; 6: 270-282
139. Heuvel OA van den, Veltman DJ, Groenewegen HJ et al. Frontal-striatal dysfunction during planning in obsessive-compulsive disorder. Arch Gen Psychiatry 2005; 62: 301-309
140. Baxter LR Jr, Schwartz JM, Bergman KS et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992; 49: 681-689
141. Nakatani E, Nakgawa A, Ohara Y et al. Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Res 2003; 124: 113-120
142. Schwartz JM, Stoessel PW, Baxter LR et al. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Arch Gen Psychiatry 1996; 53: 109-113
143. Benazon NR, Moore GJ, Rosenberg DJ. Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. J Am Acad Child Adol Psychiatry 2003; 42: 1279-1285
144. Brody AL, Saxena S, Schwartz JM et al. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive-compulsive disorder. Psychiatry Res - Neuroimaging 1998; 84: 1-6
145. Swedo SE, Schapiro MG, Grady CL et al. Cerebral glucose metabolism in childhood onset obsessive-compulsive disorder. Arch Gen Psychiatry 1989; 46: 518-523
146. Saxena S, Brody AL, Ho ML et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 2002; 59: 250-261
147. Swedo SE, Pietrini P, Leonard HL et al. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 1992; 49: 690-694
148. Zohar J, Chopra M, Sasson Y et al. Obsessive-compulsive disorder: Serotonin and beyond. World J Biol Psychiatry 2000; 1: 92-100
149. Mansari M El, Bouchard C, Blier P. Alteration of serotonin release in the guinea pig orbito-frontal cortex by selective serotonin reuptake inhibitors. Neuropsychopharmacology 1995; 13: 117-127
150. 99mTc-HMPAO during sumatriptan challenge in obsessive-compulsive disorder: Investigating the functional role of the serotonin auto-receptor. Prog Neuropsychopharmacology Biol Psychiatry 1999; 23: 1079-1099
151. Wiggins GC, Triantafyllou C, Potthast A et al. 32-channel 3 Tesla receive-only phased-array head coil with soccer-ball element geometry. Magnetic Resonance Med 2006; 56: 216-223
152. Haken H, Schiepek G. Synergetik in der Psychologie. Selbstorganisation verstehen und gestalten. Göttingen: Hogrefe, 2006
153. Friston KJ, Harrison L, Penny W. Dynamic causal modelling. Neuroimage 2003; 19: 1273-1302
154. Weiskopf N, Veit R, Erb M et al. Physiological self-regulation of regional brain activity using real-time functional magnetic resonance imaging (fMRI): Methodology and exemplary data. Neuroimage 2003; 19: 577-586
155. Charms RC de et al. Control over barin activation and pain learned by using real-time functional MRI. PNAS 2005; 102: 18626-18631
156. Spitzer M. Therapie mit dem Scanner? Feedback gegen Schmerzen mittels Echtzeit-fMRT. Nervenheilkunde 2006; 25: 390-392
157. Staketee G. Social support and treatment outcome of obsessive-compulsive disorder at 9-month follow up. Behav Psychother 1993; 21: 81-95
158. Schiepek G, Tominschek I, Eckert H, Caine C. Monitoring: Der Psyche bei der Arbeit zuschauen. Psychol Heute 2007; 34 (1): 42-47